BioWorld MedTech

July 10, 2012

Deals roundup: Luminex in agreement to acquire GenturaDX for $50 million

Luminex (Austin, Texas) reported a definitive agreement to acquire privately-held, GenturaDx (Hayward, California), a molecular diagnostics company focused on making nucleic acid testing both affordable and practical for any laboratory. Read More

Lab tech invents system to prevent needle sticks

Report from Europe: Lab21 gets 5M from Clydesdale Bank for international expansion

Washington roundup: ACR: Part B imaging cuts for 2013 'arbitrary and capricious'

Financings roundup: CartiHeal raises up to $10M in most recent funding drive

Coming Wednesday in MDD Perspectives

Agreements/contracts: KM&T, Medworxx unite on patient flow diagnostic

People in the News

Patents roundup: Unilife secures patent for Unifill syringe technology

Med-Tech Notes: BSD sells MicroThermX to Miami hospital

Product Briefs

CareFusion recalls AirLife infant breathing product

MDD's Cardio Extra

Today's news in brief

BioWorld

BioWorld briefs for May 22, 2026.

Sangamo presents primate data for prion suppressor ST-506

BioWorld Science

Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...

TREM2 agonists detailed in Pfizer patent

BioWorld Science

Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.

Unmasking the X: EPAC2 shifts the fragile X landscape

BioWorld

Researchers at UCLA have shown that divergent neuronal signaling in fragile X mice converges on EPAC2, a druggable target whose inhibition restores circuit...

Recludix presents STAT1/3 inhibitors for dermatological diseases

BioWorld Science

Recludix Pharma Inc. recently presented data on their new STAT1/3 inhibitors REX-6553 and REX-6547 for treating dermatological inflammatory skin diseases.